Shares of Insmed (INSM) jumped nearly 30% Tuesday after the biopharmaceutical company reported positive results from a Phase 2 trial…
Read More »:max_bytes(150000):strip_icc()/GettyImages-2194283558-06b4eff0af2b4cc892d742e8db0c10af.jpg?w=780&resize=780,470&ssl=1 "Insmed Stock Soars on Pulmonary Arterial Hypertension Drug Trial Results")
Shares of Insmed (INSM) jumped nearly 30% Tuesday after the biopharmaceutical company reported positive results from a Phase 2 trial…
Read More »